nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—TOP2A—Etoposide—muscle cancer	0.296	0.406	CbGbCtD
Amsacrine—TOP2A—Doxorubicin—muscle cancer	0.202	0.277	CbGbCtD
Amsacrine—ABCB1—Dactinomycin—muscle cancer	0.0701	0.0962	CbGbCtD
Amsacrine—ABCB1—Vincristine—muscle cancer	0.0432	0.0592	CbGbCtD
Amsacrine—ABCB1—Etoposide—muscle cancer	0.0395	0.0543	CbGbCtD
Amsacrine—ABCB1—Doxorubicin—muscle cancer	0.027	0.037	CbGbCtD
Amsacrine—ABCB1—Methotrexate—muscle cancer	0.0261	0.0359	CbGbCtD
Amsacrine—CYP2D6—Doxorubicin—muscle cancer	0.0254	0.0349	CbGbCtD
Amsacrine—NCOA3—smooth muscle tissue—muscle cancer	0.0033	0.0948	CbGeAlD
Amsacrine—NCOA3—renal system—muscle cancer	0.00318	0.0912	CbGeAlD
Amsacrine—NCOA3—Idarubicin—Doxorubicin—muscle cancer	0.00304	0.343	CbGdCrCtD
Amsacrine—NCOA3—cardiac atrium—muscle cancer	0.00285	0.0817	CbGeAlD
Amsacrine—NCOA3—tendon—muscle cancer	0.00248	0.0712	CbGeAlD
Amsacrine—NCOA3—bone marrow—muscle cancer	0.0024	0.069	CbGeAlD
Amsacrine—NCOA3—vagina—muscle cancer	0.0023	0.0661	CbGeAlD
Amsacrine—NCOA3—head—muscle cancer	0.00213	0.061	CbGeAlD
Amsacrine—NCOA3—testis—muscle cancer	0.00205	0.059	CbGeAlD
Amsacrine—TOP2A—tendon—muscle cancer	0.00146	0.0418	CbGeAlD
Amsacrine—TOP2A—bone marrow—muscle cancer	0.00141	0.0405	CbGeAlD
Amsacrine—TOP2A—Vindesine—Vincristine—muscle cancer	0.00137	0.155	CbGdCrCtD
Amsacrine—TOP2A—vagina—muscle cancer	0.00135	0.0388	CbGeAlD
Amsacrine—TOP2A—testis—muscle cancer	0.00121	0.0346	CbGeAlD
Amsacrine—KCNH2—renal system—muscle cancer	0.00105	0.03	CbGeAlD
Amsacrine—KCNH2—cardiac atrium—muscle cancer	0.000936	0.0269	CbGeAlD
Amsacrine—NCOA3—Transcriptional regulation of white adipocyte differentiation—MED12—muscle cancer	0.000928	0.0776	CbGpPWpGaD
Amsacrine—Pancytopenia—Vincristine—muscle cancer	0.000921	0.00427	CcSEcCtD
Amsacrine—Agranulocytosis—Dactinomycin—muscle cancer	0.000904	0.00419	CcSEcCtD
Amsacrine—Ventricular arrhythmia—Doxorubicin—muscle cancer	0.000878	0.00407	CcSEcCtD
Amsacrine—Weight decreased—Vincristine—muscle cancer	0.000878	0.00407	CcSEcCtD
Amsacrine—Hepatitis—Dactinomycin—muscle cancer	0.000869	0.00403	CcSEcCtD
Amsacrine—TOP2A—Vinorelbine—Vincristine—muscle cancer	0.000865	0.0978	CbGdCrCtD
Amsacrine—TOP2A—Podofilox—Etoposide—muscle cancer	0.000864	0.0977	CbGdCrCtD
Amsacrine—TOP2A—Teniposide—Etoposide—muscle cancer	0.000864	0.0977	CbGdCrCtD
Amsacrine—KCNH2—Hematopoietic Stem Cell Differentiation—CSF3—muscle cancer	0.000862	0.0721	CbGpPWpGaD
Amsacrine—Extravasation—Methotrexate—muscle cancer	0.00086	0.00399	CcSEcCtD
Amsacrine—Proteinuria—Methotrexate—muscle cancer	0.000854	0.00396	CcSEcCtD
Amsacrine—Stomatitis—Vincristine—muscle cancer	0.000843	0.00391	CcSEcCtD
Amsacrine—Protein urine present—Methotrexate—muscle cancer	0.000842	0.0039	CcSEcCtD
Amsacrine—Gingivitis—Doxorubicin—muscle cancer	0.000828	0.00384	CcSEcCtD
Amsacrine—Necrosis—Doxorubicin—muscle cancer	0.000828	0.00384	CcSEcCtD
Amsacrine—Hyperuricaemia—Methotrexate—muscle cancer	0.000809	0.00375	CcSEcCtD
Amsacrine—KCNH2—bone marrow—muscle cancer	0.00079	0.0227	CbGeAlD
Amsacrine—Dysphagia—Etoposide—muscle cancer	0.000786	0.00364	CcSEcCtD
Amsacrine—Inflammation—Methotrexate—muscle cancer	0.000774	0.00359	CcSEcCtD
Amsacrine—Hypoaesthesia—Vincristine—muscle cancer	0.000773	0.00358	CcSEcCtD
Amsacrine—Alopecia—Dactinomycin—muscle cancer	0.000768	0.00356	CcSEcCtD
Amsacrine—Urinary tract disorder—Vincristine—muscle cancer	0.000767	0.00356	CcSEcCtD
Amsacrine—Blood uric acid increased—Methotrexate—muscle cancer	0.000764	0.00354	CcSEcCtD
Amsacrine—Connective tissue disorder—Vincristine—muscle cancer	0.000763	0.00354	CcSEcCtD
Amsacrine—Urethral disorder—Vincristine—muscle cancer	0.000761	0.00353	CcSEcCtD
Amsacrine—KCNH2—vagina—muscle cancer	0.000757	0.0217	CbGeAlD
Amsacrine—Pancytopenia—Etoposide—muscle cancer	0.000746	0.00346	CcSEcCtD
Amsacrine—Extravasation—Doxorubicin—muscle cancer	0.000745	0.00345	CcSEcCtD
Amsacrine—Cardiac disorder—Vincristine—muscle cancer	0.000721	0.00334	CcSEcCtD
Amsacrine—Angiopathy—Vincristine—muscle cancer	0.000705	0.00327	CcSEcCtD
Amsacrine—Aplastic anaemia—Methotrexate—muscle cancer	0.000704	0.00327	CcSEcCtD
Amsacrine—Infestation—Etoposide—muscle cancer	0.000701	0.00325	CcSEcCtD
Amsacrine—Infestation NOS—Etoposide—muscle cancer	0.000701	0.00325	CcSEcCtD
Amsacrine—Hyperuricaemia—Doxorubicin—muscle cancer	0.0007	0.00325	CcSEcCtD
Amsacrine—Mediastinal disorder—Vincristine—muscle cancer	0.0007	0.00324	CcSEcCtD
Amsacrine—Anaemia—Dactinomycin—muscle cancer	0.000699	0.00324	CcSEcCtD
Amsacrine—KCNH2—head—muscle cancer	0.000699	0.0201	CbGeAlD
Amsacrine—NCOA3—PPARA activates gene expression—MED12—muscle cancer	0.000697	0.0584	CbGpPWpGaD
Amsacrine—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—TP63—muscle cancer	0.000696	0.0583	CbGpPWpGaD
Amsacrine—Renal failure—Etoposide—muscle cancer	0.000689	0.00319	CcSEcCtD
Amsacrine—Blood bilirubin increased—Doxorubicin—muscle cancer	0.000687	0.00318	CcSEcCtD
Amsacrine—Alopecia—Vincristine—muscle cancer	0.000686	0.00318	CcSEcCtD
Amsacrine—Stomatitis—Etoposide—muscle cancer	0.000683	0.00317	CcSEcCtD
Amsacrine—Jaundice—Etoposide—muscle cancer	0.000683	0.00317	CcSEcCtD
Amsacrine—Creatinine increased—Doxorubicin—muscle cancer	0.000683	0.00316	CcSEcCtD
Amsacrine—NCOA3—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—muscle cancer	0.000682	0.0571	CbGpPWpGaD
Amsacrine—Mental disorder—Vincristine—muscle cancer	0.00068	0.00315	CcSEcCtD
Amsacrine—Leukopenia—Dactinomycin—muscle cancer	0.000677	0.00314	CcSEcCtD
Amsacrine—KCNH2—testis—muscle cancer	0.000675	0.0194	CbGeAlD
Amsacrine—Inflammation—Doxorubicin—muscle cancer	0.00067	0.00311	CcSEcCtD
Amsacrine—Hepatobiliary disease—Etoposide—muscle cancer	0.000663	0.00307	CcSEcCtD
Amsacrine—Blood uric acid increased—Doxorubicin—muscle cancer	0.000662	0.00307	CcSEcCtD
Amsacrine—Musculoskeletal pain—Doxorubicin—muscle cancer	0.000658	0.00305	CcSEcCtD
Amsacrine—Agranulocytosis—Etoposide—muscle cancer	0.000654	0.00303	CcSEcCtD
Amsacrine—Sepsis—Methotrexate—muscle cancer	0.000651	0.00302	CcSEcCtD
Amsacrine—Phosphatase alkaline increased—Doxorubicin—muscle cancer	0.00065	0.00301	CcSEcCtD
Amsacrine—Injection site reaction—Doxorubicin—muscle cancer	0.000646	0.00299	CcSEcCtD
Amsacrine—CYP2D6—renal system—muscle cancer	0.000637	0.0183	CbGeAlD
Amsacrine—Hypoaesthesia—Etoposide—muscle cancer	0.000626	0.0029	CcSEcCtD
Amsacrine—Anaemia—Vincristine—muscle cancer	0.000625	0.0029	CcSEcCtD
Amsacrine—Urinary tract disorder—Etoposide—muscle cancer	0.000621	0.00288	CcSEcCtD
Amsacrine—Urethral disorder—Etoposide—muscle cancer	0.000617	0.00286	CcSEcCtD
Amsacrine—Infection—Dactinomycin—muscle cancer	0.000613	0.00284	CcSEcCtD
Amsacrine—Blood urea increased—Doxorubicin—muscle cancer	0.000613	0.00284	CcSEcCtD
Amsacrine—Aplastic anaemia—Doxorubicin—muscle cancer	0.00061	0.00283	CcSEcCtD
Amsacrine—Hepatic failure—Methotrexate—muscle cancer	0.000606	0.00281	CcSEcCtD
Amsacrine—ABCB1—embryo—muscle cancer	0.000606	0.0174	CbGeAlD
Amsacrine—Leukopenia—Vincristine—muscle cancer	0.000605	0.00281	CcSEcCtD
Amsacrine—Thrombocytopenia—Dactinomycin—muscle cancer	0.000605	0.0028	CcSEcCtD
Amsacrine—TOP2A—Vinblastine—Vincristine—muscle cancer	0.000595	0.0672	CbGdCrCtD
Amsacrine—Anorexia—Dactinomycin—muscle cancer	0.000589	0.00273	CcSEcCtD
Amsacrine—Convulsion—Vincristine—muscle cancer	0.000586	0.00272	CcSEcCtD
Amsacrine—Cardiac disorder—Etoposide—muscle cancer	0.000584	0.00271	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—MYF6—muscle cancer	0.000576	0.0482	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—MYF5—muscle cancer	0.000576	0.0482	CbGpPWpGaD
Amsacrine—Angiopathy—Etoposide—muscle cancer	0.000571	0.00265	CcSEcCtD
Amsacrine—Mediastinal disorder—Etoposide—muscle cancer	0.000567	0.00263	CcSEcCtD
Amsacrine—Sepsis—Doxorubicin—muscle cancer	0.000564	0.00261	CcSEcCtD
Amsacrine—Alopecia—Etoposide—muscle cancer	0.000556	0.00258	CcSEcCtD
Amsacrine—Lethargy—Methotrexate—muscle cancer	0.000556	0.00258	CcSEcCtD
Amsacrine—Infection—Vincristine—muscle cancer	0.000548	0.00254	CcSEcCtD
Amsacrine—Phlebitis—Doxorubicin—muscle cancer	0.000547	0.00254	CcSEcCtD
Amsacrine—Blood alkaline phosphatase increased—Doxorubicin—muscle cancer	0.000542	0.00251	CcSEcCtD
Amsacrine—Thrombocytopenia—Vincristine—muscle cancer	0.00054	0.0025	CcSEcCtD
Amsacrine—Decreased appetite—Dactinomycin—muscle cancer	0.000537	0.00249	CcSEcCtD
Amsacrine—Fatigue—Dactinomycin—muscle cancer	0.000532	0.00247	CcSEcCtD
Amsacrine—Pain—Dactinomycin—muscle cancer	0.000528	0.00245	CcSEcCtD
Amsacrine—Vascular purpura—Doxorubicin—muscle cancer	0.000527	0.00244	CcSEcCtD
Amsacrine—Anorexia—Vincristine—muscle cancer	0.000526	0.00244	CcSEcCtD
Amsacrine—Hepatic failure—Doxorubicin—muscle cancer	0.000525	0.00243	CcSEcCtD
Amsacrine—Cardiac failure congestive—Doxorubicin—muscle cancer	0.00052	0.00241	CcSEcCtD
Amsacrine—Mood swings—Methotrexate—muscle cancer	0.000516	0.00239	CcSEcCtD
Amsacrine—Hypotension—Vincristine—muscle cancer	0.000516	0.00239	CcSEcCtD
Amsacrine—Feeling abnormal—Dactinomycin—muscle cancer	0.000509	0.00236	CcSEcCtD
Amsacrine—Anaemia—Etoposide—muscle cancer	0.000506	0.00235	CcSEcCtD
Amsacrine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000505	0.00234	CcSEcCtD
Amsacrine—Paraesthesia—Vincristine—muscle cancer	0.000495	0.0023	CcSEcCtD
Amsacrine—Leukopenia—Etoposide—muscle cancer	0.00049	0.00227	CcSEcCtD
Amsacrine—Purpura—Doxorubicin—muscle cancer	0.000489	0.00227	CcSEcCtD
Amsacrine—Abdominal pain—Dactinomycin—muscle cancer	0.000488	0.00226	CcSEcCtD
Amsacrine—Body temperature increased—Dactinomycin—muscle cancer	0.000488	0.00226	CcSEcCtD
Amsacrine—Lethargy—Doxorubicin—muscle cancer	0.000481	0.00223	CcSEcCtD
Amsacrine—Decreased appetite—Vincristine—muscle cancer	0.00048	0.00222	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Vincristine—muscle cancer	0.000476	0.00221	CcSEcCtD
Amsacrine—Fatigue—Vincristine—muscle cancer	0.000476	0.00221	CcSEcCtD
Amsacrine—Convulsion—Etoposide—muscle cancer	0.000474	0.0022	CcSEcCtD
Amsacrine—Pain—Vincristine—muscle cancer	0.000472	0.00219	CcSEcCtD
Amsacrine—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—muscle cancer	0.00047	0.0394	CbGpPWpGaD
Amsacrine—Affect lability—Doxorubicin—muscle cancer	0.000464	0.00215	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000463	0.00215	CcSEcCtD
Amsacrine—ABCB1—renal system—muscle cancer	0.000458	0.0132	CbGeAlD
Amsacrine—Hypersensitivity—Dactinomycin—muscle cancer	0.000455	0.00211	CcSEcCtD
Amsacrine—NCOA3—Androgen receptor signaling pathway—FOXO1—muscle cancer	0.000453	0.0379	CbGpPWpGaD
Amsacrine—Gastrointestinal pain—Vincristine—muscle cancer	0.000451	0.00209	CcSEcCtD
Amsacrine—Confusional state—Etoposide—muscle cancer	0.000451	0.00209	CcSEcCtD
Amsacrine—Pancytopenia—Methotrexate—muscle cancer	0.000447	0.00207	CcSEcCtD
Amsacrine—Mood swings—Doxorubicin—muscle cancer	0.000447	0.00207	CcSEcCtD
Amsacrine—Infection—Etoposide—muscle cancer	0.000444	0.00206	CcSEcCtD
Amsacrine—Asthenia—Dactinomycin—muscle cancer	0.000443	0.00205	CcSEcCtD
Amsacrine—Blood creatinine increased—Doxorubicin—muscle cancer	0.000442	0.00205	CcSEcCtD
Amsacrine—Thrombocytopenia—Etoposide—muscle cancer	0.000438	0.00203	CcSEcCtD
Amsacrine—Tachycardia—Etoposide—muscle cancer	0.000436	0.00202	CcSEcCtD
Amsacrine—Abdominal pain—Vincristine—muscle cancer	0.000436	0.00202	CcSEcCtD
Amsacrine—Body temperature increased—Vincristine—muscle cancer	0.000436	0.00202	CcSEcCtD
Amsacrine—Skin disorder—Etoposide—muscle cancer	0.000434	0.00201	CcSEcCtD
Amsacrine—CYP2D6—head—muscle cancer	0.000426	0.0122	CbGeAlD
Amsacrine—Anorexia—Etoposide—muscle cancer	0.000426	0.00197	CcSEcCtD
Amsacrine—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000425	0.00197	CcSEcCtD
Amsacrine—Diarrhoea—Dactinomycin—muscle cancer	0.000423	0.00196	CcSEcCtD
Amsacrine—Infestation—Methotrexate—muscle cancer	0.00042	0.00195	CcSEcCtD
Amsacrine—Infestation NOS—Methotrexate—muscle cancer	0.00042	0.00195	CcSEcCtD
Amsacrine—Hypotension—Etoposide—muscle cancer	0.000418	0.00194	CcSEcCtD
Amsacrine—TOP2A—Epirubicin—Doxorubicin—muscle cancer	0.000417	0.0471	CbGdCrCtD
Amsacrine—TOP2A—Idarubicin—Doxorubicin—muscle cancer	0.000417	0.0471	CbGdCrCtD
Amsacrine—TOP2A—Daunorubicin—Doxorubicin—muscle cancer	0.000417	0.0471	CbGdCrCtD
Amsacrine—Renal failure—Methotrexate—muscle cancer	0.000413	0.00191	CcSEcCtD
Amsacrine—CYP2D6—testis—muscle cancer	0.000412	0.0118	CbGeAlD
Amsacrine—Stomatitis—Methotrexate—muscle cancer	0.000409	0.0019	CcSEcCtD
Amsacrine—Dysphagia—Doxorubicin—muscle cancer	0.000408	0.00189	CcSEcCtD
Amsacrine—Hypersensitivity—Vincristine—muscle cancer	0.000406	0.00188	CcSEcCtD
Amsacrine—Paraesthesia—Etoposide—muscle cancer	0.000401	0.00186	CcSEcCtD
Amsacrine—Haematuria—Methotrexate—muscle cancer	0.0004	0.00186	CcSEcCtD
Amsacrine—Dyspnoea—Etoposide—muscle cancer	0.000398	0.00185	CcSEcCtD
Amsacrine—Hepatobiliary disease—Methotrexate—muscle cancer	0.000397	0.00184	CcSEcCtD
Amsacrine—Asthenia—Vincristine—muscle cancer	0.000396	0.00184	CcSEcCtD
Amsacrine—Vomiting—Dactinomycin—muscle cancer	0.000393	0.00182	CcSEcCtD
Amsacrine—Agranulocytosis—Methotrexate—muscle cancer	0.000392	0.00182	CcSEcCtD
Amsacrine—Rash—Dactinomycin—muscle cancer	0.000389	0.0018	CcSEcCtD
Amsacrine—Decreased appetite—Etoposide—muscle cancer	0.000389	0.0018	CcSEcCtD
Amsacrine—Pancytopenia—Doxorubicin—muscle cancer	0.000387	0.00179	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Etoposide—muscle cancer	0.000386	0.00179	CcSEcCtD
Amsacrine—Fatigue—Etoposide—muscle cancer	0.000385	0.00179	CcSEcCtD
Amsacrine—Pain—Etoposide—muscle cancer	0.000382	0.00177	CcSEcCtD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—FOXO4—muscle cancer	0.00038	0.0318	CbGpPWpGaD
Amsacrine—Haemoglobin—Methotrexate—muscle cancer	0.000379	0.00176	CcSEcCtD
Amsacrine—Diarrhoea—Vincristine—muscle cancer	0.000377	0.00175	CcSEcCtD
Amsacrine—Haemorrhage—Methotrexate—muscle cancer	0.000377	0.00175	CcSEcCtD
Amsacrine—Hepatitis—Methotrexate—muscle cancer	0.000377	0.00175	CcSEcCtD
Amsacrine—Urinary tract disorder—Methotrexate—muscle cancer	0.000372	0.00173	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—MYOG—muscle cancer	0.000371	0.0311	CbGpPWpGaD
Amsacrine—Weight increased—Doxorubicin—muscle cancer	0.000371	0.00172	CcSEcCtD
Amsacrine—Urethral disorder—Methotrexate—muscle cancer	0.000369	0.00171	CcSEcCtD
Amsacrine—Weight decreased—Doxorubicin—muscle cancer	0.000369	0.00171	CcSEcCtD
Amsacrine—Feeling abnormal—Etoposide—muscle cancer	0.000368	0.00171	CcSEcCtD
Amsacrine—Nausea—Dactinomycin—muscle cancer	0.000367	0.0017	CcSEcCtD
Amsacrine—Gastrointestinal pain—Etoposide—muscle cancer	0.000365	0.00169	CcSEcCtD
Amsacrine—Dizziness—Vincristine—muscle cancer	0.000365	0.00169	CcSEcCtD
Amsacrine—Infestation NOS—Doxorubicin—muscle cancer	0.000363	0.00168	CcSEcCtD
Amsacrine—Infestation—Doxorubicin—muscle cancer	0.000363	0.00168	CcSEcCtD
Amsacrine—Renal failure—Doxorubicin—muscle cancer	0.000357	0.00166	CcSEcCtD
Amsacrine—Urticaria—Etoposide—muscle cancer	0.000355	0.00165	CcSEcCtD
Amsacrine—Jaundice—Doxorubicin—muscle cancer	0.000354	0.00164	CcSEcCtD
Amsacrine—Stomatitis—Doxorubicin—muscle cancer	0.000354	0.00164	CcSEcCtD
Amsacrine—Body temperature increased—Etoposide—muscle cancer	0.000353	0.00164	CcSEcCtD
Amsacrine—Abdominal pain—Etoposide—muscle cancer	0.000353	0.00164	CcSEcCtD
Amsacrine—Vomiting—Vincristine—muscle cancer	0.000351	0.00163	CcSEcCtD
Amsacrine—Cardiac disorder—Methotrexate—muscle cancer	0.00035	0.00162	CcSEcCtD
Amsacrine—Rash—Vincristine—muscle cancer	0.000348	0.00161	CcSEcCtD
Amsacrine—Dermatitis—Vincristine—muscle cancer	0.000348	0.00161	CcSEcCtD
Amsacrine—ABCB1—bone marrow—muscle cancer	0.000347	0.00995	CbGeAlD
Amsacrine—Haematuria—Doxorubicin—muscle cancer	0.000347	0.00161	CcSEcCtD
Amsacrine—Headache—Vincristine—muscle cancer	0.000346	0.0016	CcSEcCtD
Amsacrine—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000344	0.00159	CcSEcCtD
Amsacrine—Angiopathy—Methotrexate—muscle cancer	0.000342	0.00158	CcSEcCtD
Amsacrine—Mediastinal disorder—Methotrexate—muscle cancer	0.00034	0.00157	CcSEcCtD
Amsacrine—Agranulocytosis—Doxorubicin—muscle cancer	0.000339	0.00157	CcSEcCtD
Amsacrine—Alopecia—Methotrexate—muscle cancer	0.000333	0.00154	CcSEcCtD
Amsacrine—Bradycardia—Doxorubicin—muscle cancer	0.000332	0.00154	CcSEcCtD
Amsacrine—ABCB1—vagina—muscle cancer	0.000332	0.00953	CbGeAlD
Amsacrine—Mental disorder—Methotrexate—muscle cancer	0.00033	0.00153	CcSEcCtD
Amsacrine—Hypersensitivity—Etoposide—muscle cancer	0.000329	0.00153	CcSEcCtD
Amsacrine—Malnutrition—Methotrexate—muscle cancer	0.000328	0.00152	CcSEcCtD
Amsacrine—Haemoglobin—Doxorubicin—muscle cancer	0.000328	0.00152	CcSEcCtD
Amsacrine—Nausea—Vincristine—muscle cancer	0.000328	0.00152	CcSEcCtD
Amsacrine—Haemorrhage—Doxorubicin—muscle cancer	0.000326	0.00151	CcSEcCtD
Amsacrine—Hepatitis—Doxorubicin—muscle cancer	0.000326	0.00151	CcSEcCtD
Amsacrine—Hypoaesthesia—Doxorubicin—muscle cancer	0.000325	0.0015	CcSEcCtD
Amsacrine—Urinary tract disorder—Doxorubicin—muscle cancer	0.000322	0.00149	CcSEcCtD
Amsacrine—Asthenia—Etoposide—muscle cancer	0.000321	0.00149	CcSEcCtD
Amsacrine—Connective tissue disorder—Doxorubicin—muscle cancer	0.000321	0.00149	CcSEcCtD
Amsacrine—Urethral disorder—Doxorubicin—muscle cancer	0.00032	0.00148	CcSEcCtD
Amsacrine—Vision blurred—Methotrexate—muscle cancer	0.000309	0.00143	CcSEcCtD
Amsacrine—ABCB1—head—muscle cancer	0.000307	0.0088	CbGeAlD
Amsacrine—Diarrhoea—Etoposide—muscle cancer	0.000306	0.00142	CcSEcCtD
Amsacrine—Anaemia—Methotrexate—muscle cancer	0.000303	0.00141	CcSEcCtD
Amsacrine—Cardiac disorder—Doxorubicin—muscle cancer	0.000303	0.0014	CcSEcCtD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—TP73—muscle cancer	0.000299	0.0251	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—FOXO1—muscle cancer	0.000297	0.0249	CbGpPWpGaD
Amsacrine—ABCB1—testis—muscle cancer	0.000296	0.0085	CbGeAlD
Amsacrine—Angiopathy—Doxorubicin—muscle cancer	0.000296	0.00137	CcSEcCtD
Amsacrine—Dizziness—Etoposide—muscle cancer	0.000296	0.00137	CcSEcCtD
Amsacrine—Mediastinal disorder—Doxorubicin—muscle cancer	0.000294	0.00136	CcSEcCtD
Amsacrine—Leukopenia—Methotrexate—muscle cancer	0.000294	0.00136	CcSEcCtD
Amsacrine—Arrhythmia—Doxorubicin—muscle cancer	0.000291	0.00135	CcSEcCtD
Amsacrine—Alopecia—Doxorubicin—muscle cancer	0.000288	0.00134	CcSEcCtD
Amsacrine—Mental disorder—Doxorubicin—muscle cancer	0.000286	0.00133	CcSEcCtD
Amsacrine—Convulsion—Methotrexate—muscle cancer	0.000284	0.00132	CcSEcCtD
Amsacrine—Vomiting—Etoposide—muscle cancer	0.000284	0.00132	CcSEcCtD
Amsacrine—Malnutrition—Doxorubicin—muscle cancer	0.000284	0.00132	CcSEcCtD
Amsacrine—Rash—Etoposide—muscle cancer	0.000282	0.00131	CcSEcCtD
Amsacrine—Dermatitis—Etoposide—muscle cancer	0.000282	0.00131	CcSEcCtD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—FOXO1—muscle cancer	0.000281	0.0235	CbGpPWpGaD
Amsacrine—Headache—Etoposide—muscle cancer	0.00028	0.0013	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000277	0.00129	CcSEcCtD
Amsacrine—NCOA3—Androgen receptor signaling pathway—MDM2—muscle cancer	0.000272	0.0228	CbGpPWpGaD
Amsacrine—Confusional state—Methotrexate—muscle cancer	0.00027	0.00125	CcSEcCtD
Amsacrine—Vision blurred—Doxorubicin—muscle cancer	0.000268	0.00124	CcSEcCtD
Amsacrine—Infection—Methotrexate—muscle cancer	0.000266	0.00123	CcSEcCtD
Amsacrine—Nausea—Etoposide—muscle cancer	0.000265	0.00123	CcSEcCtD
Amsacrine—Anaemia—Doxorubicin—muscle cancer	0.000263	0.00122	CcSEcCtD
Amsacrine—Thrombocytopenia—Methotrexate—muscle cancer	0.000262	0.00122	CcSEcCtD
Amsacrine—Skin disorder—Methotrexate—muscle cancer	0.00026	0.00121	CcSEcCtD
Amsacrine—Anorexia—Methotrexate—muscle cancer	0.000255	0.00118	CcSEcCtD
Amsacrine—Leukopenia—Doxorubicin—muscle cancer	0.000254	0.00118	CcSEcCtD
Amsacrine—Hypotension—Methotrexate—muscle cancer	0.00025	0.00116	CcSEcCtD
Amsacrine—Convulsion—Doxorubicin—muscle cancer	0.000246	0.00114	CcSEcCtD
Amsacrine—Paraesthesia—Methotrexate—muscle cancer	0.00024	0.00111	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00024	0.00111	CcSEcCtD
Amsacrine—Dyspnoea—Methotrexate—muscle cancer	0.000239	0.00111	CcSEcCtD
Amsacrine—Confusional state—Doxorubicin—muscle cancer	0.000234	0.00108	CcSEcCtD
Amsacrine—Decreased appetite—Methotrexate—muscle cancer	0.000233	0.00108	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000231	0.00107	CcSEcCtD
Amsacrine—Fatigue—Methotrexate—muscle cancer	0.000231	0.00107	CcSEcCtD
Amsacrine—Infection—Doxorubicin—muscle cancer	0.00023	0.00107	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—MYOD1—muscle cancer	0.000229	0.0192	CbGpPWpGaD
Amsacrine—Pain—Methotrexate—muscle cancer	0.000229	0.00106	CcSEcCtD
Amsacrine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000227	0.00105	CcSEcCtD
Amsacrine—Tachycardia—Doxorubicin—muscle cancer	0.000226	0.00105	CcSEcCtD
Amsacrine—Skin disorder—Doxorubicin—muscle cancer	0.000225	0.00104	CcSEcCtD
Amsacrine—Anorexia—Doxorubicin—muscle cancer	0.000221	0.00102	CcSEcCtD
Amsacrine—Feeling abnormal—Methotrexate—muscle cancer	0.000221	0.00102	CcSEcCtD
Amsacrine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000219	0.00101	CcSEcCtD
Amsacrine—Hypotension—Doxorubicin—muscle cancer	0.000217	0.001	CcSEcCtD
Amsacrine—Urticaria—Methotrexate—muscle cancer	0.000213	0.000986	CcSEcCtD
Amsacrine—Body temperature increased—Methotrexate—muscle cancer	0.000212	0.000981	CcSEcCtD
Amsacrine—Abdominal pain—Methotrexate—muscle cancer	0.000212	0.000981	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—MED12—muscle cancer	0.00021	0.0175	CbGpPWpGaD
Amsacrine—Paraesthesia—Doxorubicin—muscle cancer	0.000208	0.000965	CcSEcCtD
Amsacrine—Dyspnoea—Doxorubicin—muscle cancer	0.000207	0.000958	CcSEcCtD
Amsacrine—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—muscle cancer	0.000205	0.0172	CbGpPWpGaD
Amsacrine—Decreased appetite—Doxorubicin—muscle cancer	0.000202	0.000934	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.0002	0.000928	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.0002	0.0167	CbGpPWpGaD
Amsacrine—Fatigue—Doxorubicin—muscle cancer	0.0002	0.000926	CcSEcCtD
Amsacrine—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—muscle cancer	0.000199	0.0166	CbGpPWpGaD
Amsacrine—Pain—Doxorubicin—muscle cancer	0.000198	0.000919	CcSEcCtD
Amsacrine—Hypersensitivity—Methotrexate—muscle cancer	0.000197	0.000914	CcSEcCtD
Amsacrine—Asthenia—Methotrexate—muscle cancer	0.000192	0.00089	CcSEcCtD
Amsacrine—Feeling abnormal—Doxorubicin—muscle cancer	0.000191	0.000886	CcSEcCtD
Amsacrine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00019	0.000879	CcSEcCtD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000187	0.0157	CbGpPWpGaD
Amsacrine—Urticaria—Doxorubicin—muscle cancer	0.000184	0.000854	CcSEcCtD
Amsacrine—Body temperature increased—Doxorubicin—muscle cancer	0.000183	0.00085	CcSEcCtD
Amsacrine—Abdominal pain—Doxorubicin—muscle cancer	0.000183	0.00085	CcSEcCtD
Amsacrine—Diarrhoea—Methotrexate—muscle cancer	0.000183	0.000849	CcSEcCtD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—MDM2—muscle cancer	0.000178	0.0149	CbGpPWpGaD
Amsacrine—Dizziness—Methotrexate—muscle cancer	0.000177	0.000821	CcSEcCtD
Amsacrine—Hypersensitivity—Doxorubicin—muscle cancer	0.000171	0.000792	CcSEcCtD
Amsacrine—Vomiting—Methotrexate—muscle cancer	0.00017	0.000789	CcSEcCtD
Amsacrine—Rash—Methotrexate—muscle cancer	0.000169	0.000782	CcSEcCtD
Amsacrine—Dermatitis—Methotrexate—muscle cancer	0.000169	0.000782	CcSEcCtD
Amsacrine—Headache—Methotrexate—muscle cancer	0.000168	0.000777	CcSEcCtD
Amsacrine—Asthenia—Doxorubicin—muscle cancer	0.000166	0.000771	CcSEcCtD
Amsacrine—TOP2A—Gastric Cancer Network 2—TP53—muscle cancer	0.000159	0.0133	CbGpPWpGaD
Amsacrine—Nausea—Methotrexate—muscle cancer	0.000159	0.000737	CcSEcCtD
Amsacrine—Diarrhoea—Doxorubicin—muscle cancer	0.000159	0.000735	CcSEcCtD
Amsacrine—Dizziness—Doxorubicin—muscle cancer	0.000153	0.000711	CcSEcCtD
Amsacrine—CYP2D6—Melatonin metabolism and effects—FOXO1—muscle cancer	0.000151	0.0127	CbGpPWpGaD
Amsacrine—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000148	0.0124	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—FH—muscle cancer	0.000148	0.0124	CbGpPWpGaD
Amsacrine—Vomiting—Doxorubicin—muscle cancer	0.000147	0.000683	CcSEcCtD
Amsacrine—Rash—Doxorubicin—muscle cancer	0.000146	0.000678	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	0.000146	0.0122	CbGpPWpGaD
Amsacrine—Dermatitis—Doxorubicin—muscle cancer	0.000146	0.000677	CcSEcCtD
Amsacrine—Headache—Doxorubicin—muscle cancer	0.000145	0.000673	CcSEcCtD
Amsacrine—Nausea—Doxorubicin—muscle cancer	0.000138	0.000638	CcSEcCtD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	0.000135	0.0113	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—muscle cancer	0.000121	0.0102	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—FOXO1—muscle cancer	0.000115	0.00963	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—TP53—muscle cancer	0.000102	0.00856	CbGpPWpGaD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—CDKN2A—muscle cancer	8.81e-05	0.00738	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—MED12—muscle cancer	8.34e-05	0.00698	CbGpPWpGaD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—muscle cancer	8.04e-05	0.00673	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ENO2—muscle cancer	7.6e-05	0.00636	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—BUB1B—muscle cancer	7.07e-05	0.00592	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—TP53—muscle cancer	6.97e-05	0.00583	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	6.58e-05	0.00551	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	6.48e-05	0.00542	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—BUB1B—muscle cancer	6.33e-05	0.00529	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	6.24e-05	0.00522	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	5.95e-05	0.00498	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—VEGFA—muscle cancer	5.58e-05	0.00467	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—VEGFA—muscle cancer	5.24e-05	0.00439	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	4.92e-05	0.00412	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	4.81e-05	0.00403	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—MDM2—muscle cancer	4.62e-05	0.00387	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	3.79e-05	0.00317	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	3.72e-05	0.00311	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—TP53—muscle cancer	3.57e-05	0.00299	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—VEGFA—muscle cancer	3.28e-05	0.00275	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN2A—muscle cancer	3.23e-05	0.0027	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDKN2A—muscle cancer	2.89e-05	0.00242	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MDM2—muscle cancer	2.8e-05	0.00235	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PTGS2—muscle cancer	2.65e-05	0.00222	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	2.13e-05	0.00178	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—FH—muscle cancer	2.13e-05	0.00178	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	2.06e-05	0.00172	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—FH—muscle cancer	2.01e-05	0.00168	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	1.62e-05	0.00136	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—TP53—muscle cancer	1.61e-05	0.00135	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	1.22e-05	0.00102	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MED12—muscle cancer	1.2e-05	0.00101	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MED12—muscle cancer	1.13e-05	0.000949	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ENO2—muscle cancer	1.1e-05	0.000919	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ENO2—muscle cancer	1.03e-05	0.000866	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PTGS2—muscle cancer	3.82e-06	0.00032	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PTGS2—muscle cancer	3.6e-06	0.000301	CbGpPWpGaD
